According to our analysis, lncRNA AC003092.1 was an immune-related eRNA with significant correlation to survival in patients with GBM and upregulated target gene, TFPI2 (tissue factor pathway inhibitor 2), expression. Here, TFPI2 is linked to glioblastoma.